The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial
Open Access
- 10 December 2015
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 16 (1) , 1-9
Abstract
Concern that mild iodine deficiency in pregnancy may adversely affect neurodevelopment of offspring has led to recommendations for iodine supplementation in the absence of evidence from randomised controlled trials. The primary objective of the study was to investigate the effect of iodine supplementation during pregnancy on childhood neurodevelopment. Secondary outcomes included pregnancy outcomes, maternal thyroid function and general health. Women with a singleton pregnancy of fewer than 20 weeks were randomly assigned to iodine (150 μg/d) or placebo from trial entry to birth. Childhood neurodevelopment was assessed at 18 months by using Bayley Scales of Infant and Toddler Development (Bayley-III). Iodine status and thyroid function were assessed at baseline and at 36 weeks’ gestation. Pregnancy outcomes were collected from medical records. The trial was stopped after 59 women were randomly assigned following withdrawal of support by the funding body. There were no differences in childhood neurodevelopmental scores between the iodine treated and placebo groups. The mean cognitive, language and motor scores on the Bayley-III (iodine versus placebo, respectively) were 99.4 ± 12.2 versus 101.7 ± 8.2 (mean difference (MD) −2.3, 95 % confidence interval (CI) −7.8, 3.2; P = 0.42), 97.2 ± 12.2 versus 97.9 ± 11.5 (MD −0.7, 95 % CI −7.0, 5.6; P = 0.83) and 93.9 ± 10.8 versus 92.4 ± 9.7 (MD 1.4, 95 % CI −4.0, 6.9; P = 0.61), respectively. No differences were identified between groups in any secondary outcomes. Iodine supplementation in pregnancy did not result in better childhood neurodevelopment in this small trial. Adequately powered randomised controlled trials are needed to provide conclusive evidence regarding the effect of iodine supplementation in pregnancy. The trial was registered with the Australian New Zealand Clinical Trials Registry at http://www.anzctr.org.au . The registration number of this trial is ACTRN12610000411044 . The trial was registered on 21 May 2010.Keywords
This publication has 24 references indexed in Scilit:
- Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trialsThe American Journal of Clinical Nutrition, 2013
- Iodine Supplementation During Pregnancy and Infant Neuropsychological Development: INMA Mother and Child Cohort StudyAmerican Journal of Epidemiology, 2013
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and PostpartumThyroid®, 2011
- Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young ChildrenJAMA, 2010
- The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997Archives of Disease in Childhood, 2009
- Delayed Neurobehavioral Development in Children Born to Pregnant Women with Mild Hypothyroxinemia During the First Month of Gestation: The Importance of Early Iodine SupplementationThyroid®, 2009
- Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a reviewThe American Journal of Clinical Nutrition, 2009
- Iodine requirements during pregnancy, lactation and the neonatal period and indicators of optimal iodine nutritionPublic Health Nutrition, 2007
- The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sampleBritish Journal of Clinical Psychology, 2005
- NEUROLOGICAL DAMAGE TO THE FETUS RESULTING FROM SEVERE IODINE DEFICIENCY DURING PREGNANCYThe Lancet, 1971